← All trials
NCT05330130
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2022
- Primary completion
- Oct 31, 2022
- Completion date
- Nov 30, 2022
- First posted
- Apr 15, 2022
- Last posted
- Jun 30, 2022
- Enrollment
- 10
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- ART Fertility Clinics LLCLead sponsor
- OrganonCollaborator
- ART Fertility Clinics LLCOverall official - principal investigator
- ART Fertility Clinics LLCReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.